Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...

Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its ...

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...

Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...

Genetic engineering, also known as genetic modification, is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to ...

Dallas-based biotech firm Colossal Biosciences has announced the successful de-extinction of the dire wolf, a prehistoric predator that vanished some 12,500 years ago. The company revealed that three ...

He showed that specialized cells retain the genes to form an organism.

The evolution of biomedical science can be appreciated through studies of hemoglobin, the oxygen-carrying protein in red cells. Before molecular cloning, the geneticist Arno Motulsky noted, “Many ...